Asparagine, a Key Metabolite in Cellular Response to Mitochondrial Dysfunction.

Area of Science:

• Oncology
• Metabolic pathways
• Mitochondrial function

Background:

• The mitochondrial electron transport chain (ETC) is crucial for tumor growth and proliferation.
• The ETC is a validated target for anti-cancer drug development.
• Metabolic reprogramming is a hallmark of cancer, offering therapeutic opportunities.

Purpose of the Study:

• To investigate the metabolic consequences of ETC dysfunction in cancer cells.
• To identify specific metabolic vulnerabilities exploitable for cancer therapy.
• To understand the role of amino acid metabolism in response to ETC inhibition.

Main Methods:

• Utilized cancer cell models with induced ETC dysfunction.
• Performed metabolic profiling to assess changes in amino acid levels.
• Analyzed the integrated stress response activation.
• Evaluated the impact of asparagine levels on cancer cell proliferation.

Main Results:

• ETC dysfunction led to a significant decrease in intracellular asparagine levels.
• Reduced asparagine availability was found to limit cancer cell proliferation.
• Asparagine depletion triggered the integrated stress response.
• These findings highlight a specific metabolic vulnerability associated with ETC dysfunction.

Conclusions:

• Targeting the mitochondrial ETC creates a metabolic vulnerability related to asparagine.
• Asparagine limitation is a key factor in controlling cancer cell proliferation under ETC stress.
• The integrated stress response is activated upon asparagine depletion, suggesting a feedback mechanism.
• This metabolic vulnerability presents a potential therapeutic strategy for cancer treatment.